Zantac’s Developer Settles Lawsuits Claiming Cancer Link
GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.
GSK shares jump on $2.2 billion Zantac settlement
GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits ...
Business Times3d
GSK surges 6.5% after US$2.2 billion Zantac lawsuits settlement
SHARES of British drugmaker GSK rose as much as 6.5 per cent on Thursday (Oct 10), after it agreed to pay up to US$2.2 ...
GSK shares jump after landmark £1.68bn heartburn drug settlement
The pharmaceutical giant has settled the vast majority of cases around its drug Zantac in the US, boosting investor ...
Thousands of cancer patients in line to share £1.7bn as GSK settles Zantac cases
The predicted rise in forecourt prices comes as the amount paid by drivers for petrol has fallen by 15.5p since the start of ...
Against all odds, Victoria’s Secret survived the Great Recession. That was the easy part
Victoria’s Secret and the Unraveling of an American icon, authors Lauren Sherman and Chantal Fernandez weave together the ...
Reuters25d
Boehringer Ingelheim faces second hung jury in Chicago Zantac trial
Kimbrow, 73, said he took Zantac from 1995 to 2019. Boehringer Ingelheim, GSK, Pfizer and Sanofi (SASY.PA), opens new tab all sold brand name Zantac at various times since it was approved in 1983 ...
AOL24d
Boehringer Ingelheim faces second hung jury in Chicago Zantac trial
Kimbrow, 73, said he took Zantac from 1995 to 2019. Boehringer Ingelheim, GSK, Pfizer and Sanofi all sold brand name Zantac at various times since it was approved in 1983, and have been named in ...
GSK to pay £1.7bn to settle claims Zantac caused cancer
Tens of thousands of Americans are in line to share $2.2bn (£1.7bn) after GSK agreed a settlement over claims its indigestion drug caused cancers. The British drug giant has agreed to pay up to $2.2bn ...